References
- Armishaw, J., Hoy, J., Watson, K., Wright, E., Price, B., & Pierce, A. (2011). Non-occupational post-exposure prophylaxis in Victoria, Australia: Responding to high rates of re-presentation and low rates of follow-up. International Journal of STD & AIDS, 22(12), 714–718. https://doi.org/10.1258/ijsa.2011.011174
- Bassett, I. V., Freedberg, K. A., & Walensky, R. P. (2004). Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV. Clinical Infectious Diseases, 39(3), 395–401. https://doi.org/10.1086/422459
- Centers for Disease Control and Prevention. (2019). HIV infection risk, prevention, and testing behaviors among men who have sex with men – National HIV behavioral surveillance, 23 U.S. Cities, 2017. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-special-report-number-22.pdf
- Centers for Disease Control Prevention. (1998). Guidelines for the management of health-care workers exposure to HIV and recommendations for post exposure prophylaxis. Morbidity and Mortality Weekly Report: Recommendations and Reports, 47, 1–34. https://www.cdc.gov/mmwr/preview/mmwrhtml/00052722.htm.
- Chinese Center for Disease Control and Prevention. (2018). HIV PrEP and PEP pilot projects among MSM. http://www.chinacdc.cn/zxdt/201811/t20181122_197440.html
- Chinese Clinical Trial Registry. (2017). Study protocol: A multicenter, real-world study on two oral Truvada approaches to prevention HIV infection among men who have sex with men. 2017ZX10201101. http://www.chictr.org.cn/hvshowproject.aspx?id=12652
- Dolezal, C., Frasca, T., Giguere, R., Ibitoye, M., Cranston, R. D., Febo, I., Mayer, K. H., McGowan, I., & Carballo-Diéguez, A. (2015). Awareness of post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) is low but interest is high among men engaging in condomless anal sex with men in Boston, Pittsburgh, and San Juan. AIDS Education and Prevention, 27(4), 289–297. https://doi.org/10.1521/aeap.2015.27.4.289
- Fernández-Balbuena, S., Belza, M. J., Castilla, J., Hoyos, J., Rosales-Statkus, M. E., Sánchez, R., & de la Fuente, L. T. (2013). Awareness and use of nonoccupational HIV post-exposure prophylaxis among people receiving rapid HIV testing in Spain. HIV Medicine, 14(4), 252–257. https://doi.org/10.1111/j.1468-1293.2012.01056.x
- IBM Corp. (2013). IBM SPSS statistics for windows, version 22.0.
- Jain, S., Oldenburg, C. E., Mimiaga, M. J., & Mayer, K. H. (2015). Longitudinal trends in HIV non-occupational post-exposure prophylaxis (NPEP) use at a Boston community health center between 1997 and 2013. Journal of Acquired Immune Deficiency Syndromes (1999), 68(1), 97. https://doi.org/10.1097/QAI.0000000000000403
- Joshi, M., Basra, A., McCormick, C., Webb, H., & Pakianathan, M. (2014). Post-exposure prophylaxis after sexual exposure (PEPSE) awareness in an HIV-positive cohort. International Journal of STD & AIDS, 25(1), 67–69. https://doi.org/10.1177/0956462413491734
- Koblin, B. A., Usher, D., Nandi, V., Tieu, H.-V., Bravo, E., Lucy, D., Miles, L., Ortiz, G., Kindlon, M. J., Parisi, D. M., & Frye, V. (2018). Post-exposure prophylaxis awareness, knowledge, access and use among three populations in New York City, 2016–17. AIDS and Behavior, 22(8), 2718–2732. https://doi.org/10.1007/s10461-018-2175-5
- Krakower, D. S., Jain, S., & Mayer, K. H. (2015). Antiretrovirals for primary HIV prevention: The current status of pre-and post-exposure prophylaxis. Current HIV/AIDS Reports, 12(1), 127–138. https://doi.org/10.1007/s11904-014-0253-5
- Lin, S. Y., Lachowsky, N. J., Hull, M., Rich, A., Cui, Z., Sereda, P., Jollimore, J., Stephenson, K., Thumath, M., Montaner, J. S. G., Roth, E. A., Hogg, R. S., & Moore, D. M. (2016). Awareness and use of nonoccupational post-exposure prophylaxis among men who have sex with men in Vancouver, Canada. HIV Medicine, 17(9), 662–673. https://doi.org/10.1111/hiv.12369
- Liu, A. Y., Kittredge, P. V., Vittinghoff, E., Raymond, H. F., Ahrens, K., Matheson, T., Hecht, J., Klausner, J. D., & Buchbinder, S. P. (2008). Limited knowledge and use of HIV post-and pre-exposure prophylaxis among gay and bisexual men. Journal of Acquired Immune Deficiency Syndromes, 47(2), 241–247. doi:10.1097/QAI.0b013e31815e4041.
- Mehta, S. A., Silvera, R., Bernstein, K., Holzman, R. S., Aberg, J. A., & Daskalakis, D. C. (2011). Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York City. Sexually Transmitted Infections, 87(4), 344–348. https://doi.org/10.1136/sti.2010.046284
- Meyers, K., Wu, Y., Qian, H., Sandfort, T., Huang, X., Xu, J., Zhang, J., Xia, W., Glidden, D., Wu, H., & Shang, H. (2017). Interest in long-acting injectable PrEP in a cohort of men who have sex with men in China. Aids & Behavior, 22(27), 1–11. https://doi.org/10.1007/s10461-017-1845-z
- Minas, B., Laing, S., Jordan, H., & Mak, D. B. (2012). Improved awareness and appropriate use of non-occupational post-exposure prophylaxis (nPEP) for HIV prevention following a multi-modal communication strategy. BMC Public Health, 12(1), 906. https://doi.org/10.1186/1471-2458-12-906
- Mitchell, J. W., Sophus, A. I., & Petroll, A. E. (2016). HIV-negative partnered men’s willingness to use non-occupational post-exposure prophylaxis and associated factors in a US sample of HIV-negative and HIV-discordant male couples. LGBT Health, 3(2), 146–152. https://doi.org/10.1089/lgbt.2015.0065
- Morrison, S. A., Yoong, D., Hart, T. A., MacPherson, P., Bogoch, I., Sivarajah, V., Gough, K., Naccarato, M., Tan, D. H. S., & Garcia, J. (2018). High prevalence of syndemic health problems in patients seeking post-exposure prophylaxis for sexual exposures to HIV. PLoS One, 13(5), e0197998. https://doi.org/10.1371/journal.pone.0197998
- New York City Department of Health and Mental Hygiene. (2019). HIV surveillance annual report, 2018. https://www1.nyc.gov/assets/doh/downloads/pdf/dires/hiv-surveillance-annualreport-2018.pdf
- Palich, R., Martin-Blondel, G., Cuzin, L., Le Talec, J.-Y., Boyer, P., Massip, P., & Delobel, P. (2017). Experiences of HIV postexposure prophylaxis (PEP) among highly exposed men who have sex with men (MSM). Sexually Transmitted Infections, 93(7), 493–498. https://doi.org/10.1136/sextrans-2016-052901
- Pinkerton, S. D., Holtgrave, D. R., & Bloom, F. R. (1998). Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. Aids, 12(9), 1067–1078. https://doi.org/10.1097/00002030-199809000-00015
- Pinkerton, S. D., Martin, J. N., Roland, M. E., Katz, M. H., Coates, T. J., & Kahn, J. O. (2004). Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States. Aids, 18(15), 2065–2073. https://doi.org/10.1097/00002030-200410210-00011
- Pinto, R. M., Berringer, K. R., Melendez, R., & Mmeje, O. (2018). Improving PrEP implementation through multilevel interventions: A synthesis of the literature. AIDS and Behavior, 22(11), 3681–3691. https://doi.org/10.1007/s10461-018-2184-4
- Roedling, S., Reeves, I., Copas, A., Beattie, A., Edwards, S., Fisher, M., & Benn, P. (2008). Changes in the provision of post-exposure prophylaxis for HIV after sexual exposure following introduction of guidelines and publicity campaigns. International Journal of STD & AIDS, 19(4), 241–242. https://doi.org/10.1258/ijsa.2007.007216
- Roland, M. E., Neilands, T. B., Krone, M. R., Coates, T. J., Franses, K., Chesney, M. A., Kahn, J. S., & Martin, J. N. (2011). A randomized noninferiority trial of standard versus enhanced risk reduction and adherence counseling for individuals receiving post-exposure prophylaxis following sexual exposures to HIV. Clinical Infectious Diseases, 53(1), 76–83. https://doi.org/10.1093/cid/cir333
- San Francisco Department of Public Health. (2019). HIV epidemiology annual report 2018. https://www.sfdph.org/dph/files/reports/RptsHIVAIDS/HIV-Epidemiology-Annual-Report-2018.pdf
- Siemieniuk, R. A., Sivachandran, N., Murphy, P., Sharp, A., Walach, C., Placido, T., & Bogoch, I. I. (2015). Transitioning to HIV pre-exposure prophylaxis (PrEP) from non-occupational post-exposure prophylaxis (nPEP) in a comprehensive HIV prevention clinic: A prospective cohort study. AIDS Patient Care and STDs, 29(8), 431–436. https://doi.org/10.1089/apc.2015.0014
- Smith, D. K., Grohskopf, L. A., Black, R. J., Auerbach, J. D., Veronese, F., Struble, K. A., Cheever, L., Johnson, M., Paxton, L. A., & Onorato, I. M. (2005). Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: Recommendations from the US Department of Health and Human Services. Morbidity and Mortality Weekly Report: Recommendations and Reports, 54(2), 1–20. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5402a1.htm.
- Sullivan, P. S., Giler, R. M., Mouhanna, F., Pembleton, E. S., Guest, J. L., Jones, J., Castel, A. D., Yeung, H., Kramer, M., McCallister, S., & Siegler, A. J. (2018). Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012–2017. Annals of Epidemiology, 28(12), 833–840. https://doi.org/10.1016/j.annepidem.2018.06.009
- Sullivan, P. S., Mouhanna, F., Mera, R., Pembleton, E., Castel, A., Jaggi, C., Jones, J., Kramer, M. R., McGuinness, P., McCallister, S., & Siegler, A. J. (2020). Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the US Ending the HIV epidemic jurisdictions. Annals of Epidemiology. doi:10.1016/j.annepidem.2020.01.004.
- Walters, S. M., Rivera, A. V., Starbuck, L., Reilly, K. H., Boldon, N., Anderson, B. J., & Braunstein, S. (2017). Differences in awareness of pre-exposure prophylaxis and post-exposure prophylaxis among groups at-risk for HIV in New York State: New York City and Long Island, NY, 2011–2013. Journal of Acquired Immune Deficiency Syndromes, 75, S383–S391. https://doi.org/10.1097/QAI.0000000000001415
- Weiss, G., Smith, D. K., Newman, S., Wiener, J., Kitlas, A., & Hoover, K. W. (2018). PrEP implementation by local health departments in US cities and counties: Findings from a 2015 assessment of local health departments. PLoS One, 13, 7. https://doi.org/10.1371/journal.pone.0200338
- Wu, Y., Xie, L., Meng, S., Hou, J., Fu, R., Zheng, H., He, N., & Meyers, K. (2019). Mapping potential pre-exposure prophylaxis users onto a motivational cascade: Identifying targets to prepare for implementation in China. LGBT Health, https://doi.org/10.1089/lgbt.2018.0256
- Zablotska, I. B., Baeten, J. M., Phanuphak, N., McCormack, S., & Ong, J. (2018). Getting pre-exposure prophylaxis (PrEP) to the people: Opportunities, challenges and examples of successful health service models of PrEP implementation. CSIRO.
- Zablotska, I. B., Prestage, G., Holt, M., Poynten, M., de Wit, J., Guy, R., Mao, L., McAllister, J., & Grulich, A. E. (2011). Australian gay men who have taken nonoccupational postexposure prophylaxis for HIV are in need of effective HIV prevention methods. Journal of Acquired Immune Deficiency Syndromes, 58(4), 424–428. https://doi.org/10.1097/QAI.0b013e318230e885
- Zeng, Z., Li, Z., Lan, G.-H., Liu, H., Xu, J., & Yin, W.-Y. (2018). Qualitative study on the demand for non-occupational post-exposure prophylaxis among MSM in Guangxi Zhuang Autonomous Region. Chinese Journal of Disease Control & Prevention, 22(12), 1274–1277.
- Zeng, Z., Liu, H., Xu, J., Lan, G., Wang, L., & Yin, W. (2017). Demand for non-occupational post-exposure prophylaxis and its influencing factors among 344 men who have sex with men in Guangxi. Chinese Journal of AIDS&STD, 23(7), 620–624.